Ajinomoto launches scalable complex peptide synthesis
Ajinomoto AminoScience has launched AjiPhase, a peptide synthesis service which makes it practical and efficient to produce and scale up products that were previously considered too complex.
Ajinomoto AminoScience has launched AjiPhase, a peptide synthesis service which makes it practical and efficient to produce and scale up products that were previously considered too complex.
A project bringing together researchers from academia and pharma companies, including GSK and AZ, has received a £709,000 ($1.09m) grant to create crystals using continuous flow production.